
Technology: AstraZeneca subject to cyberattacks
Nine To Noon
00:00
Industrial espionage risks to pharma
Tony examines buyers, state interest, and how stolen IP can accelerate competing development projects.
Play episode from 07:30
Transcript

Tony examines buyers, state interest, and how stolen IP can accelerate competing development projects.